Dear fellow list members,

I would like some opinions on the scenario described below.  This
happens to be related to medical devices and specifically the MDD in the
EU but I think the same scenario can be played out for any type of
product governed by an EU CE Marking Directive

Background Info:
- Device A is compliant to 2nd Ed of 60601-1 and has its own DoC.
- Device A has been sold in the EU for years.
- Device A is considered a medical device but is always used as part of
a larger medical system, Deice B, which is also compliant to 60601-1 and
has its own DoC.
- Device A is discontinued and no longer produced and sold as a new
product but still is produced only to replace defective units in the
field that are used on Device B systems.  Device A still bears CE
Marking and has original DoC.
- MDD will require all products "placed on the market" sometime after
Jun-2012 (dependent on 60601-2-xx date in OJ) to be compliant to 3rd Ed
of 60601-1.
- New Approach Directive Guide indicates (2.1): "Products which have
been repaired (for example following a defect), without changing the
original performance, purpose or type, are not to be considered as new
products according to New Approach directives.  Thus, such products need
not undergo conformity assessment, whether or not the original product
was placed on the market before or after the directive entered into
force.  This applies even if the product has been temporarily exported
to a third county for the repair operations.  Such operations are often
carried out by replacing a defective or worn item by a spare part, which
either is identical, or at least similar, to the original spare part
(for example modifications may have taken place due to technical
progress, or discontinued production of the old part)."

Scenario:
- Device A fails in the field in the EU in 2013 and needs to be replaced
(repair not possible).  New identical replacement unit is manufactured
and sent to the EU to replace defective unit.
- The system (Device B) that Device A is used on in the field in the EU,
is still 2nd Ed compliant.

Questions:
- Does Device A shipped in 2013, strictly to replace a defective
identical unit, need to be compliant to 60601-1 3rd Ed?  If so, why?
- If not, should the device continue to bear the CE Marking and DoC to
2nd Ed even though the OJ will show 3rd Ed at this time?  If not, will
there be issues in customs with the device not bearing the CE Marking
(i.e., should the packaging be clearly marked as for replacement use
only?)?


Regards,

Nick Momcilovic
Regulatory Engineering Leader
GE Healthcare
www.gehealthcare.com

-
----------------------------------------------------------------
This message is from the IEEE Product Safety Engineering Society emc-pstc
discussion list. To post a message to the list, send your e-mail to
<emc-p...@ieee.org>

All emc-pstc postings are archived and searchable on the web at:
http://product-compliance.oc.ieee.org/
Graphics (in well-used formats), large files, etc. can be posted to that URL.

Website:  http://www.ieee-pses.org/
Instructions:  http://listserv.ieee.org/request/user-guide.html
List rules: http://www.ieee-pses.org/listrules.html

For help, send mail to the list administrators:
Scott Douglas <emcp...@radiusnorth.net>
Mike Cantwell <mcantw...@ieee.org>

For policy questions, send mail to:
Jim Bacher:  <j.bac...@ieee.org>
David Heald: <dhe...@gmail.com>

Reply via email to